![Kenneth Hoberman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Hoberman
Geschäftsführer bei
STEMLINE THERAPEUTICS, INC.
Vermögen: 19 Mio $ am 30.09.2026
Profil
Mr. Kenneth Hoberman is an Independent Director at Nuvectis Pharma, Inc., an Independent Director at TG Therapeutics, Inc. and a Chief Operating Officer at Stemline Therapeutics, Inc. He is on the Board of Directors at Lirum Therapeutics, Inc., Nuvectis Pharma, Inc. and TG Therapeutics, Inc. Mr. Hoberman was previously employed as a Vice President-Corporate & Business Development by Keryx Biopharmaceuticals, Inc. He received his undergraduate degree from Boston University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TG THERAPEUTICS, INC. 0,18 % | 11.06.2026 | 279 653 ( 0,18 % ) | 16 Mio $ | 30.09.2026 |
NUVECTIS PHARMA, INC. 0,52 % | 11.06.2026 | 168 140 ( 0,52 % ) | 4 Mio $ | 30.09.2026 |
Aktive Positionen von Kenneth Hoberman
| Unternehmen | Position | Beginn |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Geschäftsführer | 01.01.2013 |
| TG THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 15.12.2014 |
| NUVECTIS PHARMA, INC. | Direktor/Vorstandsmitglied | 01.07.2021 |
| LIRUM THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.11.2021 |
Ehemalige bekannte Positionen von Kenneth Hoberman
| Unternehmen | Position | Ende |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Corporate Officer/Principal | 01.01.2012 |
Ausbildung von Kenneth Hoberman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
51
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that focuses on the treatment of debilitating diseases | Commercial Services |
